Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Advent Venture seeds Alzheimer’s start-up CoCo Therapeutics

Executive Summary

CoCo Therapeutics Ltd., which will research the role of the nuclear receptor, retinoic acid receptor (RAR), in Alzheimer’s disease, has received an undisclosed amount of seed funding from Advent Venture Partners. An Advent general partner joined CoCo’s board as chairman.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies